查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1760591

2025年全球白血球分離術市場報告

Leukapheresis Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年，白血球分離術市場規模將強勁成長。預計到2029年，該市場規模將達到978.3億美元，複合年成長率為7.9%。預測期內的成長預計將受到以下因素的推動：個人化細胞療法需求的不斷成長、免疫腫瘤學臨床試驗的增多、再生醫學應用的日益普及、生物製藥生產規模的擴大、報銷政策的完善以及人們對基於細胞的研究和治療方案的認知的不斷提高。預測期內的主要趨勢包括細胞分離技術的開發、人工智慧在流程最佳化中的應用、可攜式白血球分離設備的開發、細胞和基因療法的進步、供體篩檢方法的改進以及雲端基礎數據追蹤系統的普及。

自體免疫疾病的日益普及預計將推動白血球分離術市場的擴張。當免疫系統錯誤地攻擊身體的健康組織時，就會引發自體免疫疾病。童年時期接觸微生物的機會減少以及現代環境的影響等因素破壞了免疫平衡，導致自體免疫疾病的發生率上升。白血球分離術透過選擇性地清除那些幫助免疫系統攻擊身體的有害白血球，從而幫助治療這些疾病。例如，根據德國機構Versorgungsatlas.de的報告，2022年，在73,241,305名參保人員中，有6,304,340人被診斷出患有至少一種自體免疫疾病，盛行率為8.61%。因此，自體免疫疾病的增多正在推動白血球分離術市場的成長。

白血球分離術市場的主要企業正專注於創新，例如開發GMP級隱色，以提高細胞療法生產的品質和效率。 GMP級隱色是指根據嚴格的良好生產規範 (GMP) 標準加工的白血球分離術衍生產品，確保細胞的高活力和治療功能。例如，2024年11月，美國生物技術公司Sanguine Biosciences推出了LeukoCer，這是隱色GMP級白血球分離包，旨在簡化工作流程並加快細胞療法的開發。 LeukoCer提供按照嚴格GMP標準生產的新鮮整包或半包高品質起始材料，使研究人員能夠推進研究並加速新型細胞療法的市場推廣。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場 - 宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球白血球分離術的 PESTEL 分析（政治、社會、技術、環境、法律、促進因素、限制因素）
  • 最終用途產業分析
  • 全球白血球分離療法市場：成長率分析
  • 全球白血球分離術市場表現：規模與成長，2019-2024 年
  • 全球白血球分離術市場預測：規模與成長，2024-2029 年，2034 年
  • 全球白血球分離療法總目標市場（TAM）

第6章市場區隔

  • 全球白血球分離術市場類型、績效及預測（2019-2024、2024-2029、2034）
  • 粒細胞成分分析
  • 淋巴球成分分析
  • 單核細胞成分分析
  • 全球白血球分離術市場（依產品、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 白血球分離裝置
  • 離心裝置
  • 膜分離器
  • 白血球分離術一次性用品
  • 全球白血球分離療法市場的應用、績效及預測（2019-2024、2024-2029、2034）
  • 研究應用
  • 癌症研究
  • 免疫學研究
  • 治療應用
  • 血液系統疾病
  • 自體免疫疾病
  • 其他
  • 全球白血球分離療法市場（依最終使用者、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 血液成分供應商和血液中心
  • 學術研究所
  • 製藥和生物技術公司
  • 醫院/輸血中心
  • 全球白血球分離術市場：粒細胞成分分析細分（按類型、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 嗜中性白血球球成分分析
  • 嗜酸性粒細胞細胞成分分析
  • 嗜鹼性球成分分析
  • 全球白血球分離療法市場：淋巴球成分分析細分（按類型、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • T細胞成分分析
  • B細胞成分分析
  • 自然殺手（NK）細胞成分分析
  • 全球白血球分離術市場：單核細胞成分分析細分（按類型、表現和預測），2019-2024 年、2024-2029 年、2034 年
  • 經典單核細胞
  • 非經典單核細胞
  • 中間單核細胞

第7章 區域和國家分析

  • 全球白血球分離療法市場（按地區、績效及預測）2019-2024、2024-2029、2034
  • 全球白血球分離療法市場（依國家/地區、績效及預測）2019-2024、2024-2029、2034

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章競爭格局與公司概況

  • 白血球分離術市場：競爭格局
  • 白血球分離術市場：公司簡介
    • Fresenius Kabi Overview, Products and Services, Strategy and Financial Analysis
    • Grifols SA Overview, Products and Services, Strategy and Financial Analysis
    • Terumo BCT Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Nikkiso Co. Overview, Products and Services, Strategy and Financial Analysis
    • STEMCELL Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

  • Haemonetics Corporation
  • Macopharma
  • Discovery Life Sciences
  • BioIVT LLC
  • StemExpress LLC
  • MEDICA SpA
  • AllCells LLC
  • Caltag Medsystems Ltd.
  • Miltenyi Biotec
  • Immune Therapy Holdings AB
  • Cellsep Laboratories
  • Accegen Biotec
  • Key Biologics LLC
  • HemaCare Corporation
  • Puriblood Medical

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

  • 2029 年白血球分離術市場：提供新機會的國家
  • 2029 年白血球分離術市場：細分領域帶來新機會
  • 2029 年白血球分離術市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第36章 附錄

簡介目錄
Product Code: r35468

Leukapheresis is a medical procedure that involves the separation and removal of white blood cells (leukocytes) from a patient's blood. The remaining blood components, such as red blood cells and plasma, are then returned to the body. This technique is used to treat conditions with elevated white blood cell counts or to collect specific immune cells for research or therapeutic purposes.

The main types of leukapheresis include granulocyte, lymphocyte, and monocyte apheresis. Granulocyte apheresis is a procedure that selectively isolates granulocytes (a type of white blood cell) from a patient's blood for therapeutic use. Products related to this procedure include leukapheresis devices, centrifugal devices, membrane separators, and disposables. Applications of leukapheresis extend to research areas such as cancer research, immunology, hematologic disorders, autoimmune diseases, and others. These procedures are utilized by blood component providers, blood centers, academic and research institutions, pharmaceutical and biotechnology companies, and hospitals and transfusion centers.

The leukapheresis market research report is one of a series of new reports from The Business Research Company that provides leukapheresis market statistics, including the leukapheresis industry global market size, regional shares, competitors with the leukapheresis market share, detailed leukapheresis market segments, market trends, and opportunities, and any further data you may need to thrive in the leukapheresis industry. This leukapheresis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The leukapheresis market size has grown strongly in recent years. It will grow from $66.80 billion in 2024 to $72.23 billion in 2025 at a compound annual growth rate (CAGR) of 8.1%. Growth during the historic period can be attributed to the increasing prevalence of leukemia and autoimmune diseases, rising demand for personalized medicine, advancements in stem cell research, improvements in apheresis technologies, expanding clinical trial activities, and greater awareness of immunotherapy applications.

The leukapheresis market size is expected to see strong growth in the next few years. It will grow to $97.83 billion in 2029 at a compound annual growth rate (CAGR) of 7.9%. Growth in the forecast period is expected to be driven by rising demand for personalized cell therapies, an increase in clinical trials in immuno-oncology, growing adoption in regenerative medicine, expansion of biopharmaceutical manufacturing, improved reimbursement policies, and greater awareness of cell-based research and treatment options. Key trends in the forecast period include advancements in cell separation technologies, integration of AI for optimizing procedures, development of portable leukapheresis devices, progress in cell and gene therapy, enhanced donor screening methods, and the adoption of cloud-based data tracking systems.

The growing incidence of autoimmune diseases is anticipated to drive the expansion of the leukapheresis market. Autoimmune diseases occur when the immune system mistakenly attacks the body's healthy tissues. Factors such as reduced early-life microbial exposure and modern environmental influences are disrupting immune balance, leading to an increase in autoimmune disorders. Leukapheresis aids in treating these diseases by selectively removing harmful white blood cells that contribute to the immune system's attack on the body. For example, according to a report by Versorgungsatlas.de, a Germany-based organization, in 2022, out of 73,241,305 insured individuals, 6,304,340 were diagnosed with at least one autoimmune disease, resulting in a prevalence rate of 8.61%. Thus, the rise in autoimmune diseases is fueling the growth of the leukapheresis market.

Leading companies in the leukapheresis market are focusing on innovations such as the development of GMP-grade leukopaks to improve the quality and efficiency of cell therapy manufacturing. GMP-grade leukopaks are leukapheresis-derived products processed under stringent good manufacturing practice (GMP) standards, ensuring high cell viability and functionality for therapeutic use. For instance, in November 2024, Sanguine Biosciences, a US-based biotechnology company, introduced LeukoCer, a GMP-grade leukopak designed to streamline workflows and speed up cell therapy development. LeukoCer provides high-quality starting materials in fresh whole or half packs, produced according to strict GMP standards, enabling researchers to advance their work and accelerate the introduction of new cell therapies to the market.

In July 2023, SCTbio, a Czech Republic-based contract development and manufacturing organization, formed a partnership with Cyto-care.eu GmbH to enhance the cryopreservation process for cell therapy in Europe. The collaboration focuses on improving the collection, cryopreservation, quality control, and logistics of leukapheresis materials, which are vital components in the production of advanced cell therapy products (ATMPs). Cyto-care.eu GmbH, based in Austria, specializes in providing cell products for biomedical research, drug discovery, and cell and gene therapy.

Major players in the leukapheresis market are Fresenius Kabi, Grifols S.A., Terumo BCT Inc., Nikkiso Co., STEMCELL Technologies Inc., Haemonetics Corporation, Macopharma, Discovery Life Sciences, BioIVT LLC, StemExpress LLC, MEDICA S.p.A, AllCells LLC, Caltag Medsystems Ltd., Miltenyi Biotec, Immune Therapy Holdings AB, Cellsep Laboratories, Accegen Biotec, Key Biologics LLC, HemaCare Corporation, Puriblood Medical, Cytopheron Technologies, and Adacyte Therapeutics.

North America was the largest region in the leukapheresis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in leukapheresis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the leukapheresis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The leukapheresis market consists of revenues earned by entities providing services such as cell collection, cell processing and storage, and custom apheresis procedures. The market value includes the value of related goods sold by the service provider or included within the service offering. The leukapheresis market also includes sales of products such as apheresis machines, centrifugal and membrane-based systems, needles & catheters, and anticoagulants and solutions. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Leukapheresis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on leukapheresis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for leukapheresis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The leukapheresis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Granulocyte Apheresis; Lymphocyte Apheresis; Monocyte Apheresis
  • 2) By Product: Leukapheresis Devices; Centrifugal Devices; Membrane Separators; Leukapheresis Disposables
  • 3) By Application: Research Application; Cancer Research; Immunology Research; Therapeutics Application; Hematologic Disorders; Autoimmune Diseases; Other Applications
  • 4) By End User: Blood Component Providers And Blood Centers; Academic And Research Institutes; Pharmaceutical And Biotechnology Companies; Hospitals And Transfusion Centers
  • Subsegments:
  • 1) By Granulocyte Apheresis: Neutrophil Apheresis; Eosinophil Apheresis; Basophil Apheresis
  • 2) By Lymphocyte Apheresis: T-Cell Apheresis; B-Cell Apheresis; Natural Killer (NK) Cell Apheresis
  • 3) By Monocyte Apheresis: Classical Monocytes; Non-Classical Monocytes; Intermediate Monocytes
  • Companies Mentioned: Fresenius Kabi; Grifols S.A.; Terumo BCT Inc.; Nikkiso Co.; STEMCELL Technologies Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Leukapheresis Market Characteristics

3. Leukapheresis Market Trends And Strategies

4. Leukapheresis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Leukapheresis Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Leukapheresis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Leukapheresis Market Growth Rate Analysis
  • 5.4. Global Leukapheresis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Leukapheresis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Leukapheresis Total Addressable Market (TAM)

6. Leukapheresis Market Segmentation

  • 6.1. Global Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Granulocyte Apheresis
  • Lymphocyte Apheresis
  • Monocyte Apheresis
  • 6.2. Global Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Leukapheresis Devices
  • Centrifugal Devices
  • Membrane Separators
  • Leukapheresis Disposables
  • 6.3. Global Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Research Application
  • Cancer Research
  • Immunology Research
  • Therapeutics Application
  • Hematologic Disorders
  • Autoimmune Diseases
  • Other Applications
  • 6.4. Global Leukapheresis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood Component Providers And Blood Centers
  • Academic And Research Institutes
  • Pharmaceutical And Biotechnology Companies
  • Hospitals And Transfusion Centers
  • 6.5. Global Leukapheresis Market, Sub-Segmentation Of Granulocyte Apheresis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Neutrophil Apheresis
  • Eosinophil Apheresis
  • Basophil Apheresis
  • 6.6. Global Leukapheresis Market, Sub-Segmentation Of Lymphocyte Apheresis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • T-Cell Apheresis
  • B-Cell Apheresis
  • Natural Killer (NK) Cell Apheresis
  • 6.7. Global Leukapheresis Market, Sub-Segmentation Of Monocyte Apheresis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Classical Monocytes
  • Non-Classical Monocytes
  • Intermediate Monocytes

7. Leukapheresis Market Regional And Country Analysis

  • 7.1. Global Leukapheresis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Leukapheresis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Leukapheresis Market

  • 8.1. Asia-Pacific Leukapheresis Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Leukapheresis Market

  • 9.1. China Leukapheresis Market Overview
  • 9.2. China Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Leukapheresis Market

  • 10.1. India Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Leukapheresis Market

  • 11.1. Japan Leukapheresis Market Overview
  • 11.2. Japan Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Leukapheresis Market

  • 12.1. Australia Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Leukapheresis Market

  • 13.1. Indonesia Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Leukapheresis Market

  • 14.1. South Korea Leukapheresis Market Overview
  • 14.2. South Korea Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Leukapheresis Market

  • 15.1. Western Europe Leukapheresis Market Overview
  • 15.2. Western Europe Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Leukapheresis Market

  • 16.1. UK Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Leukapheresis Market

  • 17.1. Germany Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Leukapheresis Market

  • 18.1. France Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Leukapheresis Market

  • 19.1. Italy Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Leukapheresis Market

  • 20.1. Spain Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Leukapheresis Market

  • 21.1. Eastern Europe Leukapheresis Market Overview
  • 21.2. Eastern Europe Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Leukapheresis Market

  • 22.1. Russia Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Leukapheresis Market

  • 23.1. North America Leukapheresis Market Overview
  • 23.2. North America Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Leukapheresis Market

  • 24.1. USA Leukapheresis Market Overview
  • 24.2. USA Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Leukapheresis Market

  • 25.1. Canada Leukapheresis Market Overview
  • 25.2. Canada Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Leukapheresis Market

  • 26.1. South America Leukapheresis Market Overview
  • 26.2. South America Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Leukapheresis Market

  • 27.1. Brazil Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Leukapheresis Market

  • 28.1. Middle East Leukapheresis Market Overview
  • 28.2. Middle East Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Leukapheresis Market

  • 29.1. Africa Leukapheresis Market Overview
  • 29.2. Africa Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Leukapheresis Market Competitive Landscape And Company Profiles

  • 30.1. Leukapheresis Market Competitive Landscape
  • 30.2. Leukapheresis Market Company Profiles
    • 30.2.1. Fresenius Kabi Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Grifols S.A. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Terumo BCT Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Nikkiso Co. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. STEMCELL Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Leukapheresis Market Other Major And Innovative Companies

  • 31.1. Haemonetics Corporation
  • 31.2. Macopharma
  • 31.3. Discovery Life Sciences
  • 31.4. BioIVT LLC
  • 31.5. StemExpress LLC
  • 31.6. MEDICA S.p.A
  • 31.7. AllCells LLC
  • 31.8. Caltag Medsystems Ltd.
  • 31.9. Miltenyi Biotec
  • 31.10. Immune Therapy Holdings AB
  • 31.11. Cellsep Laboratories
  • 31.12. Accegen Biotec
  • 31.13. Key Biologics LLC
  • 31.14. HemaCare Corporation
  • 31.15. Puriblood Medical

32. Global Leukapheresis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Leukapheresis Market

34. Recent Developments In The Leukapheresis Market

35. Leukapheresis Market High Potential Countries, Segments and Strategies

  • 35.1 Leukapheresis Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Leukapheresis Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Leukapheresis Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer